FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1490223019> ?p ?o ?g. }

• W1490223019 endingPage "222" @default.
• W1490223019 startingPage "215" @default.
• W1490223019 abstract "Summary Calreticulin, upon translocation to the cell surface, plays a critical role in the recognition of tumour cells and in experimentally induced cellular anti-tumour immunity. However, less is known about anti-calreticulin antibodies and their role in malignancies. Using enzyme-linked immunosorbent assay (ELISA), we found immunoglobulin (Ig)A and/or IgG anti-calreticulin antibodies in sera of approximately 63% of patients with hepatocellular carcinoma (HCC), 57% of patients with colorectal adenocarcinoma (CRA) and 47% of patients with pancreatic adenocarcinoma (PACA), while healthy controls, patients with viral hepatitis C and with chronic pancreatitis reached only 2%, 20% and 31% seropositivity, respectively. We found significantly elevated mean levels of IgA anti-calreticulin antibodies (P &lt; 0·001) in patients with HCC (78·7 ± 52·3 AU, mean ± standard deviation), PACA (66·5 ± 30·9 AU) and CRA (61·8 ± 25·8 AU) when compared to healthy controls (41·4 ± 19·2 AU). Significantly elevated mean levels of IgG anti-calreticulin antibodies (P &lt; 0·001) were detected in patients with HCC (121·9 ± 94·2 AU), gall bladder adenocarcinoma (118·4 ± 80·0 AU) and PACA (88·7 ± 55·6 AU) when compared to healthy controls (56·7 ± 22·9 AU). Pepscan analysis revealed a large number of antigenic epitopes of calreticulin recognized by both IgA and IgG antibodies of patients with HCC and PACA, indicating robust systemic immune response. Moreover, significantly elevated levels of antibodies against peptide KGEWKPRQIDNP (P &lt; 0·001) in these patients, tested by ELISA, confirmed the distinct character of antibody reactivity against calreticulin. The high occurrence and specificity of serum anti-calreticulin autoantibodies in the majority of patients with some gastrointestinal malignancies provide the evidence for their possible clinical relevance." @default.
• W1490223019 created "2016-06-24" @default.
• W1490223019 creator A5018848077 @default.
• W1490223019 creator A5037465680 @default.
• W1490223019 creator A5056805771 @default.
• W1490223019 creator A5057758780 @default.
• W1490223019 creator A5058395012 @default.
• W1490223019 creator A5063824937 @default.
• W1490223019 creator A5068596046 @default.
• W1490223019 creator A5076754329 @default.
• W1490223019 creator A5080286523 @default.
• W1490223019 creator A5082130476 @default.
• W1490223019 creator A5090562096 @default.
• W1490223019 date "2009-12-17" @default.
• W1490223019 modified "2023-10-03" @default.
• W1490223019 title "Calreticulin is a B cell molecular target in some gastrointestinal malignancies" @default.
• W1490223019 cites W1932582448 @default.
• W1490223019 cites W1973069722 @default.
• W1490223019 cites W1976066035 @default.
• W1490223019 cites W1984068314 @default.
• W1490223019 cites W1985091069 @default.
• W1490223019 cites W1988988227 @default.
• W1490223019 cites W1992604276 @default.
• W1490223019 cites W1997440969 @default.
• W1490223019 cites W2006083151 @default.
• W1490223019 cites W2008260469 @default.
• W1490223019 cites W2016612145 @default.
• W1490223019 cites W2029778026 @default.
• W1490223019 cites W2032676889 @default.
• W1490223019 cites W2032702362 @default.
• W1490223019 cites W2048796991 @default.
• W1490223019 cites W2054264041 @default.
• W1490223019 cites W2058429885 @default.
• W1490223019 cites W2058817623 @default.
• W1490223019 cites W2079482650 @default.
• W1490223019 cites W2081272311 @default.
• W1490223019 cites W2081665298 @default.
• W1490223019 cites W2123311867 @default.
• W1490223019 cites W2142614342 @default.
• W1490223019 cites W2162415760 @default.
• W1490223019 cites W2164460491 @default.
• W1490223019 cites W2167973356 @default.
• W1490223019 cites W2169935273 @default.
• W1490223019 doi "https://doi.org/10.1111/j.1365-2249.2009.04085.x" @default.
• W1490223019 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2857944" @default.
• W1490223019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20030668" @default.
• W1490223019 hasPublicationYear "2009" @default.
• W1490223019 type Work @default.
• W1490223019 sameAs 1490223019 @default.
• W1490223019 citedByCount "22" @default.
• W1490223019 countsByYear W14902230192012 @default.
• W1490223019 countsByYear W14902230192013 @default.
• W1490223019 countsByYear W14902230192014 @default.
• W1490223019 countsByYear W14902230192015 @default.
• W1490223019 countsByYear W14902230192016 @default.
• W1490223019 countsByYear W14902230192018 @default.
• W1490223019 countsByYear W14902230192019 @default.
• W1490223019 countsByYear W14902230192020 @default.
• W1490223019 countsByYear W14902230192022 @default.
• W1490223019 countsByYear W14902230192023 @default.
• W1490223019 crossrefType "journal-article" @default.
• W1490223019 hasAuthorship W1490223019A5018848077 @default.
• W1490223019 hasAuthorship W1490223019A5037465680 @default.
• W1490223019 hasAuthorship W1490223019A5056805771 @default.
• W1490223019 hasAuthorship W1490223019A5057758780 @default.
• W1490223019 hasAuthorship W1490223019A5058395012 @default.
• W1490223019 hasAuthorship W1490223019A5063824937 @default.
• W1490223019 hasAuthorship W1490223019A5068596046 @default.
• W1490223019 hasAuthorship W1490223019A5076754329 @default.
• W1490223019 hasAuthorship W1490223019A5080286523 @default.
• W1490223019 hasAuthorship W1490223019A5082130476 @default.
• W1490223019 hasAuthorship W1490223019A5090562096 @default.
• W1490223019 hasBestOaLocation W14902230192 @default.
• W1490223019 hasConcept C126322002 @default.
• W1490223019 hasConcept C158617107 @default.
• W1490223019 hasConcept C159654299 @default.
• W1490223019 hasConcept C203014093 @default.
• W1490223019 hasConcept C2778019345 @default.
• W1490223019 hasConcept C47450691 @default.
• W1490223019 hasConcept C55493867 @default.
• W1490223019 hasConcept C71924100 @default.
• W1490223019 hasConcept C86803240 @default.
• W1490223019 hasConcept C8891405 @default.
• W1490223019 hasConcept C90924648 @default.
• W1490223019 hasConceptScore W1490223019C126322002 @default.
• W1490223019 hasConceptScore W1490223019C158617107 @default.
• W1490223019 hasConceptScore W1490223019C159654299 @default.
• W1490223019 hasConceptScore W1490223019C203014093 @default.
• W1490223019 hasConceptScore W1490223019C2778019345 @default.
• W1490223019 hasConceptScore W1490223019C47450691 @default.
• W1490223019 hasConceptScore W1490223019C55493867 @default.
• W1490223019 hasConceptScore W1490223019C71924100 @default.
• W1490223019 hasConceptScore W1490223019C86803240 @default.
• W1490223019 hasConceptScore W1490223019C8891405 @default.
• W1490223019 hasConceptScore W1490223019C90924648 @default.
• W1490223019 hasIssue "2" @default.
• W1490223019 hasLocation W14902230191 @default.
• W1490223019 hasLocation W14902230192 @default.

• next